When companies hold calls discussing drug costs with investors and analysts, “I’ve heard them ask, ‘Why didn’t you price it higher.’ I’ve never heard anybody say, ‘Why don’t you price it lower?’” Mr. Kolassa said.
Continue reading Pharmaceutical Companies Buy Rivals’ Drugs, Then Jack Up the Prices